FMC had third quarter income of $1.07 billion, up nine percent from the same quarter of 2023. In North America, revenues increased 48 percent year-over-year driven by strong volume growth. Pricing challenges in Brazil and Argentina were more than offset by volume growth. Globally, profits in the plant health business improved 11 percent with much of that growth happening with biologicals.
